GlassScriptPhysician profile
Olga Kirk
NPI 1356894091
$2,462.27
in general payments reported to CMS, 2019-2025
33 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $657 · 2023: $745 · 2024: $424 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,590 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.73 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $549.67 | 2022-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $178.13 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $172.21 | 2021-2024 | |
| Solventum Corporation | $151.62 | 2025 | Abthera, Prevena, V.A.C. Veraflo |
| Getinge USA Sales, LLC | $143.52 | 2025 | Vasoview Hemopro 2 |
| Pfizer INC. | $139.05 | 2021-2024 | |
| Janssen Biotech, INC. | $136.17 | 2023-2024 | Erleada, Balversa, Akeega |
| Boston Scientific Corporation | $102.69 | 2021-2024 | Rezum Generator, Ams 700 Cxr Rte Kit |
| Sumitomo Pharma America, INC. | $94.75 | 2023-2024 | Orgovyx, Gemtesa |
| Hollister Incorporated | $93.95 | 2021-2023 | New Image, Vapro Pocket |
| Abiomed | $71.19 | 2025 | |
| Astellas Pharma US INC | $58.41 | 2022-2023 | Myrbetriq |
| Axonics, INC. | $58.07 | 2023-2024 | Axonics, Bulkamid |
| 180 Medical, INC. | $41.34 | 2022 | |
| Tolmar, INC. | $40.17 | 2023-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $39.54 | 2022 | |
| Ferring Pharmaceuticals INC. | $35.24 | 2024 | Adstiladrin |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.38 | 2025 | Lifevest |
| Angiodynamics, INC. | $32.35 | 2022 | |
| Becton, Dickinson and Company | $30.60 | 2025 | Arista |
| Tolmar Pharmaceuticals, INC. | $29.70 | 2021-2022 | |
| Myovant Sciences INC. | $29.66 | 2021-2022 | |
| Urovant Sciences INC | $27.03 | 2022 | |
| Myriad Genetic Laboratories, INC. | $21.77 | 2024 | Myrisk |
| Atricure, INC. | $21.18 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Endo Pharmaceuticals INC. | $19.83 | 2023 | Xiaflex, Aveed |
| Alnylam Pharmaceuticals INC. | $19.41 | 2024 | Givlaari |
| Antares Pharma, INC. | $18.16 | 2022 | |
| Halozyme INC | $16.33 | 2023 | |
| Ethicon US, LLC | $15.67 | 2025 | Stratafix, Ethicon, Vistaseal |
| Allergan, INC. | $15.26 | 2021 | |
| Monaghan Medical Corporation | $13.49 | 2023 | Aeroeclipse |
| Coloplast Corp | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.